Current Pharmacogenomics and Personalized Medicine
Title: Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health)
Volume: 9 Issue: 3
Author(s): Sanaa M. Kamal, Louise Warnich, Lynnette R. Ferguson, Sanjeeva Srivastava, Sandipan Ray, Denise Avard, Yann Joly, Michael Le Huynh, Madeline Page, Mario Masellis, Edward S. Dove, David Gurwitz and Vural Ozdemir
Affiliation:
Keywords: Africa, essential diagnostics model list, essential medicines, global public health, pharmacogenomics research funding and development aid, political determinants of health, postgenomics personalized medicine, women's health, Human Genome Sequence, Polymorphism
Export Options
About this article
Cite this article as:
M. Kamal Sanaa, Warnich Louise, R. Ferguson Lynnette, Srivastava Sanjeeva, Ray Sandipan, Avard Denise, Joly Yann, Le Huynh Michael, Page Madeline, Masellis Mario, S. Dove Edward, Gurwitz David and Ozdemir Vural, Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health), Current Pharmacogenomics and Personalized Medicine 2011; 9 (3) . https://dx.doi.org/10.2174/187569211796957511
DOI https://dx.doi.org/10.2174/187569211796957511 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?
Current Cancer Drug Targets Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Combined <i>Curcuma longa</i> and <i>Cratoxylum formosum</i> Extracts Possess Anti-liver Cancer and Anti-HBV Activities in HepG2.2.15
Current Traditional Medicine High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
Current Drug Targets Liver and Pancreatic Disease in Cystic Fibrosis: Clinics and Drug Therapy
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Current Bioactive Azole-Containing Natural Products
Current Bioactive Compounds Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity
Current Topics in Medicinal Chemistry Isovitexin Inhibits Stemness and Induces Apoptosis in Hepatocellular Carcinoma SK-Hep-1 Spheroids by Upregulating miR-34a Expression
Anti-Cancer Agents in Medicinal Chemistry The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells
Current Cancer Drug Targets Gallium Phthalocyanine Photosensitizers: Carboxylation Enhances the Cellular Uptake and Improves the Photodynamic Therapy of Cancers
Anti-Cancer Agents in Medicinal Chemistry Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins
Current Drug Targets Mechanisms of Tumor Cell Necrosis
Current Pharmaceutical Design Poly(Ethylene Glycol) Amphiphilic Copolymer for Anticancer Drugs Delivery
Anti-Cancer Agents in Medicinal Chemistry Transposons for Gene Therapy!
Current Gene Therapy Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
Current Medicinal Chemistry Acute and Sub-chronic Toxicity Analyses of Hot-Water Extract of Isaria japonica from Silkworm (Bombyx mori) Pupae
Current Traditional Medicine Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
Current Pharmaceutical Design An Overview of Innovations in Analysis and Beneficial Health Effects of Wine Polyphenols
Mini-Reviews in Medicinal Chemistry Cancer Stem Cells Switch on Tumor Neovascularization
Current Molecular Medicine Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets